My Cart [ 0 ]
Home > Chemicals > Inhibitors, Activators, Antagonists, and Agonists > A-Z Inhibitors, Activators, Antagonists, and Agonists > GSK690693

GSK690693

Catalog No. Product Name Size List Price (US$) Quantity
APIM050170 GSK690693 5 mg 100.00
APIM050170 GSK690693 10 mg 140.00
APIM050170 GSK690693 50mg 300.00
APIM050170 GSK690693 100 mg 500.00
APIM050170 GSK690693 200 mg 800.00
Description

Background Information:

A novel ATP competitive, pan-AKT kinase inhibitor with IC50 values of 2, 13, and 9 nM against AKT1, 2, and 3, respectively. It inhibits GSK3β phosphorylation and tumor growth in human breast carcinoma (BT474) xenografts, and induces growth inhibition and apoptosis in acute lymphoblastic leukemia cell lines.

Reference:

1. M.C. Crouthamel, J.A. Kahana, S. Korenchuk, S.Y. Zhang, G. Sundaresan, D.J. Eberwein, K.K. Brown, R. Kumar. Mechanism and management of AKT inhibitor-induced hyperglycemia. Clin. Cancer Res. 2009, 15(1), 217-225.
2. Dirk A. Heerding, Nelson Rhodes, Jack D. Leber, et al., Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT Kinase, J. Med. Chem., 2008, 51 (18), 5663-5679.
3. D.S. Levy, J.A. Kahana, R. Kumar. AKT inhibitor, GSK690693, induces growth inhibition and apoptosis in acute lymphoblastic leukemia cell lines, Blood. 2009, 113(8), 1723-1729.

APIM050170: GSK690693

CAS No.: 937174-76-0.
Molecular Formula: C21H27N7O3 ? 0.6HCl.
Molecular Weight: 447.4.
Purity: >99.5% chem and optical purity (HPLC and chiral HPLC at 220 nm).
QC: HPLC-MS, 1HNMR, Chiral HPLC, and Quantitative Elemental Analysis.
Solubility: In DMSO, Water with 1 eq of acid.
Storage: Store at 0°C (short term), -20°C (long term), desiccated.

Related Links

See our Privacy Policy